Natixis Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.32M | Sell |
140,742
-3,003
| -2% | -$156K | 0.01% | 726 |
|
2025
Q1 | $9.17M | Buy |
143,745
+24,311
| +20% | +$1.55M | 0.02% | 672 |
|
2024
Q4 | $5.71M | Sell |
119,434
-2,126
| -2% | -$102K | 0.01% | 788 |
|
2024
Q3 | $6.96M | Buy |
121,560
+56,461
| +87% | +$3.23M | 0.01% | 745 |
|
2024
Q2 | $3.41M | Buy |
65,099
+11,763
| +22% | +$616K | 0.01% | 887 |
|
2024
Q1 | $2.17M | Buy |
53,336
+15,012
| +39% | +$611K | 0.01% | 1013 |
|
2023
Q4 | $1.42M | Sell |
38,324
-6,496
| -14% | -$240K | ﹤0.01% | 1105 |
|
2023
Q3 | $1.71M | Buy |
44,820
+1,790
| +4% | +$68.4K | 0.01% | 1024 |
|
2023
Q2 | $1.55M | Buy |
43,030
+13,655
| +46% | +$493K | ﹤0.01% | 1045 |
|
2023
Q1 | $1.12M | Sell |
29,375
-21,414
| -42% | -$818K | ﹤0.01% | 1113 |
|
2022
Q4 | $2.89M | Buy |
50,789
+8,131
| +19% | +$463K | 0.01% | 836 |
|
2022
Q3 | $1.69M | Buy |
42,658
+4,818
| +13% | +$191K | 0.01% | 943 |
|
2022
Q2 | $1.67M | Buy |
37,840
+7,621
| +25% | +$335K | 0.01% | 964 |
|
2022
Q1 | $1.21M | Buy |
30,219
+3,928
| +15% | +$157K | ﹤0.01% | 1084 |
|
2021
Q4 | $1.06M | Sell |
26,291
-3,629
| -12% | -$146K | ﹤0.01% | 1112 |
|
2021
Q3 | $1.22M | Sell |
29,920
-3,773
| -11% | -$153K | 0.01% | 1050 |
|
2021
Q2 | $1.53M | Buy |
33,693
+1,989
| +6% | +$90.3K | 0.01% | 997 |
|
2021
Q1 | $1.32M | Buy |
31,704
+8,312
| +36% | +$346K | 0.01% | 989 |
|
2020
Q4 | $999K | Sell |
23,392
-28,925
| -55% | -$1.24M | 0.01% | 1015 |
|
2020
Q3 | $1.38M | Buy |
52,317
+130
| +0.2% | +$3.42K | 0.01% | 887 |
|
2020
Q2 | $1.4M | Buy |
+52,187
| New | +$1.4M | 0.01% | 890 |
|